Exact Mass: 327.1008

Exact Mass Matches: 327.1008

Found 163 metabolites which its exact mass value is equals to given mass value 327.1008, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Terrestriamide

Terrestriamide

C18H17NO5 (327.1107)


   

deoxyviolacein

deoxyviolacein

C20H13N3O2 (327.1008)


A member of the class of oxindoles resulting from formal oxidative coupling between the 3-position of 1,3-dihydro-2H-indol-2-one and the 3-position of 1,3-dihydro-2H-pyrrol-2-one, which is substituted at the 5 position by a 1H-indol-3-yl group, where the newly-formed double bond has E configuration.

   

Acetaminophen glucuronide

(2S,3S,4S,5R,6S)-6-(4-acetamidophenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C14H17NO8 (327.0954)


Acetaminophen glucuronide is a natural human metabolite of Acetaminophen generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Acetaminophen glucuronide is found to be associated with beta-thalassemia, which is an inborn error of metabolism. Acetaminophen glucuronide is a natural human metabolite of Acetaminophen generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. [HMDB]

   

N-(4-Hydroxycinnamoyl)tyrosine

2-{[(2E)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}-3-(4-hydroxyphenyl)propanoate

C18H17NO5 (327.1107)


Natural food antioxidant. Isolated from cocoa liquor (Theobroma cacao). N-(4-Hydroxycinnamoyl)tyrosine is found in cocoa and cocoa products and cocoa powder. N-(4-Hydroxycinnamoyl)tyrosine is found in cocoa and cocoa products. Natural food antioxidant. It is isolated from cocoa liquor (Theobroma cacao).

   

Blepharin

2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1,4-benzoxazin-3-one

C14H17NO8 (327.0954)


Glycoside from seedlings of rye and sweet corn (Zea mays). Blepharin is found in cereals and cereal products, fats and oils, and corn. Blepharin is found in cereals and cereal products. Blepharin is a glycoside from seedlings of rye and sweet corn (Zea mays

   

Bisindolylmaleimide IV

3,4-bis(1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione

C20H13N3O2 (327.1008)


   

(2S,3S,4S,5R)-6-(4-Acetamidophenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

3,4,5-Trihydroxy-6-{4-[(1-hydroxyethylidene)amino]phenoxy}oxane-2-carboxylate

C14H17NO8 (327.0954)


   

Benzoic acid, 2-[[3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl]amino]-

Benzoic acid, 2-[[3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl]amino]-

C18H17NO5 (327.1107)


   

Leteprinim

4-[3-(6-oxo-6,9-dihydro-1H-purin-9-yl)propanamido]benzoic acid

C15H13N5O4 (327.0967)


   

(5S)-5-(7-Benzofuranyl)-8-chloro-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol

5-(1-benzofuran-7-yl)-8-chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-ol

C19H18ClNO2 (327.1026)


   

3,4-Bis(1H-indol-2-yl)pyrrole-2,5-dione

3,4-bis(1H-indol-2-yl)-2,5-dihydro-1H-pyrrole-2,5-dione

C20H13N3O2 (327.1008)


   

Clausevatine F

Clausevatine F

C18H17NO5 (327.1107)


   
   

8-Oxoerythrinine

8-Oxoerythrinine

C18H17NO5 (327.1107)


   
   

Tecleaverdoornine

Tecleaverdoornine

C18H17NO5 (327.1107)


   
   

Dihydroarcyriacyanin A

Dihydroarcyriacyanin A

C20H13N3O2 (327.1008)


   

(-)-Stephadiolamine beta-N-oxide

(-)-4alpha-Hydroxyushinsunine beta-N-oxide

C18H17NO5 (327.1107)


   

1,3-Dioxolo(4,5-g)furo(2,3-b)quinoline, 9-methoxy-4-((3-methyl-2-butenyl)oxy)-

1,3-Dioxolo(4,5-g)furo(2,3-b)quinoline, 9-methoxy-4-((3-methyl-2-butenyl)oxy)-

C18H17NO5 (327.1107)


   

Corycularicine

Corycularicine

C18H17NO5 (327.1107)


   

Acetaminophen glucuronide

Acetaminophen glucuronide

C14H17NO8 (327.0954)


   

6-nitro-2,3-diphenylquinoxaline

6-nitro-2,3-diphenylquinoxaline

C20H13N3O2 (327.1008)


   

Maybridge4_001231

Maybridge4_001231

C15H13N5O4 (327.0967)


   

Tranilast (trans-)

Tranilast (trans-)

C18H17NO5 (327.1107)


   

bisindolylmaleimide iv

3,4-di-1H-indol-3-yl-1H-pyrrole-2,5-dione

C20H13N3O2 (327.1008)


   

(S,E)-2-(3-(3,4-dihydroxyphenyl)acrylamido)-3-phenylpropanoic acid|2-[3-(3,4-dihydroxy-phenyl)-acryloylamino]-3-phenylpropionic acid|N-trans-caffeoyl-L-phenylalanine

(S,E)-2-(3-(3,4-dihydroxyphenyl)acrylamido)-3-phenylpropanoic acid|2-[3-(3,4-dihydroxy-phenyl)-acryloylamino]-3-phenylpropionic acid|N-trans-caffeoyl-L-phenylalanine

C18H17NO5 (327.1107)


   

8-Oxoerythraline_epoxide

8-Oxoerythraline_epoxide

C18H17NO5 (327.1107)


   

1-(2-hydroxy-4-methoxyphenylamino)-1-deoxy-beta-D-glucopyranoside-1,2-carbamate

1-(2-hydroxy-4-methoxyphenylamino)-1-deoxy-beta-D-glucopyranoside-1,2-carbamate

C14H17NO8 (327.0954)


   

8-Hydroxy-5,7-Dimethoxy-4-(4-methoxyphenyl)-2(1H)-quinolinone

8-Hydroxy-5,7-Dimethoxy-4-(4-methoxyphenyl)-2(1H)-quinolinone

C18H17NO5 (327.1107)


   

proviolacein

proviolacein

C20H13N3O2 (327.1008)


A hydroxyindole that is 2H-pyrrol-2-one which is substituted at positions 3 and 5 by 1H-indol-3-yl and 5-hydroxy-1H-indol-3-yl groups, respectively. It is an intermediate in the biosynthesis of the purple chromobacterial pigment violacein from L-tryptophan.

   

Fontaphilline

Fontaphilline

C18H17NO5 (327.1107)


   

clausenawalline K

clausenawalline K

C18H17NO5 (327.1107)


   

6-Hydroxystaurosporinone

6-Hydroxystaurosporinone

C20H13N3O2 (327.1008)


   

3,4-dihydroxymandelonitrile beta-D-glucoside

3,4-dihydroxymandelonitrile beta-D-glucoside

C14H17NO8 (327.0954)


   

p-acetamidophenylglucuronide

p-acetamidophenylglucuronide

C14H17NO8 (327.0954)


   

Tranilast (SB 252218)

Tranilast (SB 252218)

C18H17NO5 (327.1107)


   

Hedysarimcoumestan E

Hedysarimcoumestan E

C20H13N3O2 (327.1008)


   

(-)-N-[4-Hydroxy-(E)-cinnamoyl]-L-tyrosine

(-)-N-[4-Hydroxy-(E)-cinnamoyl]-L-tyrosine

C18H17NO5 (327.1107)


   

C18H17NO5_L-Tyrosine, N-[(2Z)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]

NCGC00385225-01_C18H17NO5_L-Tyrosine, N-[(2Z)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-

C18H17NO5 (327.1107)


   

C18H17NO5_L-Tyrosine, N-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]

NCGC00385093-01_C18H17NO5_L-Tyrosine, N-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-

C18H17NO5 (327.1107)


   

Tranilast

2-[[3(3,4-dimethoxyphenyl)-1-oxo-2-propen-1-yl]amino]-benzoic acid

C18H17NO5 (327.1107)


D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000700 - Analgesics C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D018926 - Anti-Allergic Agents Tranilast (MK-341) acts as an anti-atopic agent. Tranilast suppresses production of prostaglandin D2 (PGD2, IC50= 0.1 mM). Tranilast sodium exhibits anti-inflammatory and immunomodulatory effects[1]. Tranilast sodium antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells[2]. trans-Tranilast (trans-MK-341) is an antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis. Target: Angiotensin Receptor Tranilast has been approved in Japan and South Korea, since 1982, for the treatment of bronchial asthma, with indications for keloids and hypertrophic scar added in 1993. Tranilast is also used to treat asthma, autoimmune diseases, atopic and fibrotic pathologies, and can also inhibit angiogenesis. The antiproliferative properties of tranilast were found that tranilast elicited an inhibitory effect on fibroblast proliferation in vitro and also suppressed collagen production both in vitro and in vivo . Tranilast also reduced the release of chemical mediators from mast cells and suppressed hypersensitivity reactions. [1] Three-week-old C57Bl/10 and mdx mice received tranilast (~300 mg/kg) in their food for 9 weeks, after which fibrosis was assessed through histological analyses, and functional properties of tibialis anterior muscles were assessed in situ and diaphragm muscle strips in vitro. Tranilast administration did not significantly alter the mass of any muscles in control or mdx mice, but it decreased fibrosis in the severely affected diaphragm muscle by 31\% compared with untreated mdx mice (P< 0.05) [2].

   

(2S)-3-(4-hydroxyphenyl)-2-[[(Z)-3-(4-hydroxyphenyl)prop-2-enoyl]amino]propanoic acid

(2S)-3-(4-hydroxyphenyl)-2-[[(Z)-3-(4-hydroxyphenyl)prop-2-enoyl]amino]propanoic acid

C18H17NO5 (327.1107)


   

HBOA + O-Hex

HBOA + O-Hex

C14H17NO8 (327.0954)


Annotation level-3

   

Acetaminophen-glucuronide; LC-tDDA; CE10

Acetaminophen-glucuronide; LC-tDDA; CE10

C14H17NO8 (327.0954)


   

Acetaminophen-glucuronide; LC-tDDA; CE20

Acetaminophen-glucuronide; LC-tDDA; CE20

C14H17NO8 (327.0954)


   

Acetaminophen-glucuronide; LC-tDDA; CE30

Acetaminophen-glucuronide; LC-tDDA; CE30

C14H17NO8 (327.0954)


   

Acetaminophen-glucuronide; LC-tDDA; CE40

Acetaminophen-glucuronide; LC-tDDA; CE40

C14H17NO8 (327.0954)


   

Acetaminophen glucuronide; AIF; CE0; CorrDec

Acetaminophen glucuronide; AIF; CE0; CorrDec

C14H17NO8 (327.0954)


   

Acetaminophen glucuronide; AIF; CE10; CorrDec

Acetaminophen glucuronide; AIF; CE10; CorrDec

C14H17NO8 (327.0954)


   

Acetaminophen glucuronide; AIF; CE30; CorrDec

Acetaminophen glucuronide; AIF; CE30; CorrDec

C14H17NO8 (327.0954)


   

Acetaminophen glucuronide; AIF; CE0; MS2Dec

Acetaminophen glucuronide; AIF; CE0; MS2Dec

C14H17NO8 (327.0954)


   

Acetaminophen glucuronide; AIF; CE10; MS2Dec

Acetaminophen glucuronide; AIF; CE10; MS2Dec

C14H17NO8 (327.0954)


   

Acetaminophen glucuronide; AIF; CE30; MS2Dec

Acetaminophen glucuronide; AIF; CE30; MS2Dec

C14H17NO8 (327.0954)


   

PC(2:0/1:0)[U]

3,5,9-Trioxa-4-phosphaundecan-1-aminium, 7-(formyloxy)-4-hydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide

C11H22NO8P (327.1083)


   

p-Acetamidophenyl glucuronide

p-Acetamidophenyl glucuronide

C14H17NO8 (327.0954)


   

Blepharin

2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1,4-benzoxazin-3-one

C14H17NO8 (327.0954)


   

N-trans-P-Coumaroyltyrosine

3-(4-hydroxyphenyl)-2-[(2E)-3-(4-hydroxyphenyl)prop-2-enamido]propanoic acid

C18H17NO5 (327.1107)


   

3-[3-(4-methoxyphenoxy)-2-oxopyrrolidin-1-yl]benzoic acid

3-[3-(4-methoxyphenoxy)-2-oxopyrrolidin-1-yl]benzoic acid

C18H17NO5 (327.1107)


   

2-(3,4-DIMETHOXYBENZYL)-3-OXOISOINDOLINE-4-CARBOXYLIC ACID

2-(3,4-DIMETHOXYBENZYL)-3-OXOISOINDOLINE-4-CARBOXYLIC ACID

C18H17NO5 (327.1107)


   
   

1-ethyl-1,2-dihydro-6-hydroxy-4-methyl-5-[(2-nitrophenyl)azo]-2-oxonicotinonitrile

1-ethyl-1,2-dihydro-6-hydroxy-4-methyl-5-[(2-nitrophenyl)azo]-2-oxonicotinonitrile

C15H13N5O4 (327.0967)


   

2-CBZ-6-Hydroxy-1,2,3,4-tetrahydro-isoquinoline-1-carboxylic acid

2-CBZ-6-Hydroxy-1,2,3,4-tetrahydro-isoquinoline-1-carboxylic acid

C18H17NO5 (327.1107)


   

8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-3A,4-DIHYDRO-3H-BENZO[F]IMIDAZO[1,5-A][1,4]DIAZEPINE

8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-3A,4-DIHYDRO-3H-BENZO[F]IMIDAZO[1,5-A][1,4]DIAZEPINE

C18H15ClFN3 (327.0938)


   

2H-1-Benzopyran-2-one,7-(diethylamino)-3-(2-thienylcarbonyl)-

2H-1-Benzopyran-2-one,7-(diethylamino)-3-(2-thienylcarbonyl)-

C18H17NO3S (327.0929)


   
   

2-(1,3-DIOXOISOINDOLIN-2-YL)-1,2,3,4-TETRAHYDROCYCLOPENTA[B]INDOLE-7-CARBONITRILE

2-(1,3-DIOXOISOINDOLIN-2-YL)-1,2,3,4-TETRAHYDROCYCLOPENTA[B]INDOLE-7-CARBONITRILE

C20H13N3O2 (327.1008)


   

Fmoc-D-Ser-OH

Fmoc-D-Ser-OH

C18H17NO5 (327.1107)


   

Thiamine nitrate

Thiamine nitrate

C12H17N5O4S (327.1001)


D018977 - Micronutrients > D014815 - Vitamins Thiamine nitrate is an essential vitamin which can enhance normal neuronal actives.

   

(R,S)-FMOC-ALPHA-METHOXYGLYCINE

(R,S)-FMOC-ALPHA-METHOXYGLYCINE

C18H17NO5 (327.1107)


   

Ethyl 2-Nitro-4,5-di(1-pyrazolyl)benzoate

Ethyl 2-Nitro-4,5-di(1-pyrazolyl)benzoate

C15H13N5O4 (327.0967)


   

4-[2-(DIMETHYLAMINO)ETHYL]PIPERAZINE-1-CARBOXIMIDAMIDE HYDROIODIDE

4-[2-(DIMETHYLAMINO)ETHYL]PIPERAZINE-1-CARBOXIMIDAMIDE HYDROIODIDE

C9H22IN5 (327.092)


   

fmoc-dl-isoser-oh

fmoc-dl-isoser-oh

C18H17NO5 (327.1107)


   

[4-(1,4-dioxa-8-azaspiro[4.5]dec-8-ylsulphonyl)phenyl]boronic acid

[4-(1,4-dioxa-8-azaspiro[4.5]dec-8-ylsulphonyl)phenyl]boronic acid

C13H18BNO6S (327.0948)


   

Phenylthiohydantoin-arginine Hydrochloride

Phenylthiohydantoin-arginine Hydrochloride

C13H18ClN5OS (327.0921)


   

Verosudil

Verosudil(AR-12286)

C17H17N3O2S (327.1041)


C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

   

Disperse Yellow 119

Disperse Yellow 119

C15H13N5O4 (327.0967)


   

Methyl 4,6-O-[(S)-(4-nitrophenyl)methylene]-alpha-D-galactopyranoside

Methyl 4,6-O-[(S)-(4-nitrophenyl)methylene]-alpha-D-galactopyranoside

C14H17NO8 (327.0954)


   

N(ALPHA)-BOC-O-(DIMETHYLPHOSPHO)-L-THREO

N(ALPHA)-BOC-O-(DIMETHYLPHOSPHO)-L-THREO

C11H22NO8P (327.1083)


   

7,7-dimethyl-3-[(3-nitrophenyl)methyl]-6,8-dihydrochromene-2,5-dione

7,7-dimethyl-3-[(3-nitrophenyl)methyl]-6,8-dihydrochromene-2,5-dione

C18H17NO5 (327.1107)


   

PTH-arginine hydrochloride

PTH-arginine hydrochloride

C13H18ClN5OS (327.0921)


   

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride

C14H18ClN3O4 (327.0986)


   

4-Methyl-N-methyl-N-(2-phenyl-2H-pyrazol-3-YL)benzenesulfonamide

4-Methyl-N-methyl-N-(2-phenyl-2H-pyrazol-3-YL)benzenesulfonamide

C17H17N3O2S (327.1041)


   

Leteprinim

Leteprinim

C15H13N5O4 (327.0967)


C26170 - Protective Agent > C1509 - Neuroprotective Agent

   

(+)-5-(7-benzofuranyl)-8-chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-ol

(+)-5-(7-benzofuranyl)-8-chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-ol

C19H18ClNO2 (327.1026)


   

1H-3-Benzazepin-7-ol, 5-(7-benzofuranyl)-8-chloro-2,3,4,5-tetrahydro-3-methyl-, (S)-

1H-3-Benzazepin-7-ol, 5-(7-benzofuranyl)-8-chloro-2,3,4,5-tetrahydro-3-methyl-, (S)-

C19H18ClNO2 (327.1026)


   

N-cis-p-Coumaroyltyrosine

N-cis-p-Coumaroyltyrosine

C18H17NO5 (327.1107)


   

4-[3-Methylsulfanylanilino]-6,7-dimethoxyquinazoline

4-[3-Methylsulfanylanilino]-6,7-dimethoxyquinazoline

C17H17N3O2S (327.1041)


   

5-(Acetylamino)-3,5-Dideoxy-3-Fluoro-D-Erythro-Alpha-L-Manno-Non-2-Ulopyranosonic Acid

5-(Acetylamino)-3,5-Dideoxy-3-Fluoro-D-Erythro-Alpha-L-Manno-Non-2-Ulopyranosonic Acid

C11H18FNO9 (327.0966)


   

7-hydroxy-K252c

7-hydroxy-K252c

C20H13N3O2 (327.1008)


   

(R)-3,4-dihydroxymandelonitrile beta-D-glucoside

(R)-3,4-dihydroxymandelonitrile beta-D-glucoside

C14H17NO8 (327.0954)


   

N-p-Coumaroyltyrosine

N-p-Coumaroyltyrosine

C18H17NO5 (327.1107)


   

3-[(4-methoxybenzylidene)amino]-2,5,6-trimethylthieno[2,3-d]pyrimidin-4(3H)-one

3-[(4-methoxybenzylidene)amino]-2,5,6-trimethylthieno[2,3-d]pyrimidin-4(3H)-one

C17H17N3O2S (327.1041)


   

4-(3,4-dimethoxyphenyl)-N-(3-methyl-2-pyridinyl)-2-thiazolamine

4-(3,4-dimethoxyphenyl)-N-(3-methyl-2-pyridinyl)-2-thiazolamine

C17H17N3O2S (327.1041)


   

N-((2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methyl)-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine

N-((2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methyl)-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine

C17H17N3O2S (327.1041)


   

8-[2-(4-Chloro-3,5-dimethylphenoxy)ethoxy]quinoline

8-[2-(4-Chloro-3,5-dimethylphenoxy)ethoxy]quinoline

C19H18ClNO2 (327.1026)


   

8-[2-(4-Chloro-2,5-dimethylphenoxy)ethoxy]quinoline

8-[2-(4-Chloro-2,5-dimethylphenoxy)ethoxy]quinoline

C19H18ClNO2 (327.1026)


   

2-[(3-ethyl-2-quinolinyl)thio]-N-(5-methyl-3-isoxazolyl)acetamide

2-[(3-ethyl-2-quinolinyl)thio]-N-(5-methyl-3-isoxazolyl)acetamide

C17H17N3O2S (327.1041)


   

5-(2,5-difluorophenyl)-N-(2,6-dimethylphenyl)-2-furancarboxamide

5-(2,5-difluorophenyl)-N-(2,6-dimethylphenyl)-2-furancarboxamide

C19H15F2NO2 (327.1071)


   

3-(4-methoxyphenyl)-3-(1-pyrrolyl)-N-(2-thiazolyl)propanamide

3-(4-methoxyphenyl)-3-(1-pyrrolyl)-N-(2-thiazolyl)propanamide

C17H17N3O2S (327.1041)


   
   

N-(3-methoxyphenyl)-N-[6-oxo-4-(trifluoromethyl)-1,6-dihydro-2-pyrimidinyl]guanidine

N-(3-methoxyphenyl)-N-[6-oxo-4-(trifluoromethyl)-1,6-dihydro-2-pyrimidinyl]guanidine

C13H12F3N5O2 (327.0943)


   

N(6)-(3-O-phospho-D-erythrulosyl)-L-lysine

N(6)-(3-O-phospho-D-erythrulosyl)-L-lysine

C10H20N2O8P- (327.0957)


   
   
   

6-methyl-7-oxo-8-(1-D-ribityl)lumazine

6-methyl-7-oxo-8-(1-D-ribityl)lumazine

C12H15N4O7- (327.0941)


   

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-propanoyloxypropyl] propanoate

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-propanoyloxypropyl] propanoate

C11H22NO8P (327.1083)


   

Lnape 4:0/N-2:0

Lnape 4:0/N-2:0

C11H22NO8P (327.1083)


   

Lnape 2:0/N-4:0

Lnape 2:0/N-4:0

C11H22NO8P (327.1083)


   

Lnape 3:0/N-3:0

Lnape 3:0/N-3:0

C11H22NO8P (327.1083)


   

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] butanoate

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] butanoate

C11H22NO8P (327.1083)


   

acetaminophen O-beta-D-glucosiduronic acid

acetaminophen O-beta-D-glucosiduronic acid

C14H17NO8 (327.0954)


A beta-D-glucosiduronic acid that is the O-glucuronide of paracetamol (acetaminophen).

   

N-(4-Hydroxycinnamoyl)tyrosine

N-(4-Hydroxycinnamoyl)tyrosine

C18H17NO5 (327.1107)


   

2-[3-(3,4-dimethoxyphenyl)prop-2-enoylamino]benzoic acid

2-[3-(3,4-dimethoxyphenyl)prop-2-enoylamino]benzoic acid

C18H17NO5 (327.1107)


   

Dimethoxyphenylpropenoylaminobenzoic acid

Dimethoxyphenylpropenoylaminobenzoic acid

C18H17NO5 (327.1107)


   

M1001

M1001

C17H17N3O2S (327.1041)


M1001 is a weak hypoxia-inducible factor-2α (HIF-2α) agonist. M1001 can bind to the HIF-2α PAS-B domain, with a Kd of 667 nM. M1001 can be used in chronic kidney disease research[1].

   

(1s,2r)-1,6-dihydroxy-2-(2-hydroxypropan-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one

(1s,2r)-1,6-dihydroxy-2-(2-hydroxypropan-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one

C18H17NO5 (327.1107)


   

n-[(1z,3e)-1,4-bis(3,4-dihydroxyphenyl)-3-methylbuta-1,3-dien-2-yl]carboximidic acid

n-[(1z,3e)-1,4-bis(3,4-dihydroxyphenyl)-3-methylbuta-1,3-dien-2-yl]carboximidic acid

C18H17NO5 (327.1107)


   

3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-6,12-diol

3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-6,12-diol

C20H13N3O2 (327.1008)


   

12-hydroxy-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,15,17-pentaen-11-one

12-hydroxy-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,15,17-pentaen-11-one

C18H17NO5 (327.1107)


   

(1s,2r)-1,2,9-trihydroxy-3,3-dimethyl-1h,2h,11h-pyrano[3,2-a]carbazole-5-carbaldehyde

(1s,2r)-1,2,9-trihydroxy-3,3-dimethyl-1h,2h,11h-pyrano[3,2-a]carbazole-5-carbaldehyde

C18H17NO5 (327.1107)


   

3-[(3z)-2-hydroxy-5-(1h-indol-3-yl)pyrrol-3-ylidene]indol-2-ol

3-[(3z)-2-hydroxy-5-(1h-indol-3-yl)pyrrol-3-ylidene]indol-2-ol

C20H13N3O2 (327.1008)


   

(1s,11r,19r)-11-hydroxy-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,15,17-pentaen-14-one

(1s,11r,19r)-11-hydroxy-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,15,17-pentaen-14-one

C18H17NO5 (327.1107)


   

(2e,4e)-n-[2-(4-hydroxy-6-oxopyran-2-yl)ethyl]-5-(4-hydroxyphenyl)penta-2,4-dienimidic acid

(2e,4e)-n-[2-(4-hydroxy-6-oxopyran-2-yl)ethyl]-5-(4-hydroxyphenyl)penta-2,4-dienimidic acid

C18H17NO5 (327.1107)


   

(2e)-3-(4-hydroxy-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)-2-oxoethyl]prop-2-enimidic acid

(2e)-3-(4-hydroxy-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)-2-oxoethyl]prop-2-enimidic acid

C18H17NO5 (327.1107)


   

bisindolylpyrrole cpb-53-594-6

NA

C20H13N3O2 (327.1008)


{"Ingredient_id": "HBIN018627","Ingredient_name": "bisindolylpyrrole cpb-53-594-6","Alias": "NA","Ingredient_formula": "C20H13N3O2","Ingredient_Smile": "C1=CC=C2C(=C1)C(=CN2)C3=C(C(=O)NC3=O)C4=CNC5=CC=CC=C54","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2476","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-[5-hydroxy-4-(1h-indol-3-yl)-1h-pyrrol-2-yl]indol-2-one

3-[5-hydroxy-4-(1h-indol-3-yl)-1h-pyrrol-2-yl]indol-2-one

C20H13N3O2 (327.1008)


   

(9r,11r,12r,13r)-9,13-dihydroxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-ium-11-olate

(9r,11r,12r,13r)-9,13-dihydroxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-ium-11-olate

C18H17NO5 (327.1107)


   

(2r,3s,4r,5r,6s)-2-{[(2r)-3-hydroxy-2h-1,4-benzoxazin-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3s,4r,5r,6s)-2-{[(2r)-3-hydroxy-2h-1,4-benzoxazin-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C14H17NO8 (327.0954)


   

3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-7,12-diol

3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-7,12-diol

C20H13N3O2 (327.1008)


   

(9r,12r,13r)-9,13-dihydroxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-ium-11-olate

(9r,12r,13r)-9,13-dihydroxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-ium-11-olate

C18H17NO5 (327.1107)


   

(1s,2s)-1,6-dihydroxy-2-(2-hydroxypropan-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one

(1s,2s)-1,6-dihydroxy-2-(2-hydroxypropan-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one

C18H17NO5 (327.1107)


   

(3ar,5r,6s,7s,7ar)-6,7-dihydroxy-3-(2-hydroxy-4-methoxyphenyl)-5-(hydroxymethyl)-tetrahydro-3ah-pyrano[2,3-d][1,3]oxazol-2-one

(3ar,5r,6s,7s,7ar)-6,7-dihydroxy-3-(2-hydroxy-4-methoxyphenyl)-5-(hydroxymethyl)-tetrahydro-3ah-pyrano[2,3-d][1,3]oxazol-2-one

C14H17NO8 (327.0954)


   

3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),13,17(22),18,20-decaene-7,14-diol

3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),13,17(22),18,20-decaene-7,14-diol

C20H13N3O2 (327.1008)


   

2-{[1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

2-{[1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C18H17NO5 (327.1107)


   

(2s,3r,4s,5s,6r)-2-{[(2s)-3-hydroxy-2h-1,4-benzoxazin-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(2s)-3-hydroxy-2h-1,4-benzoxazin-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C14H17NO8 (327.0954)


   

14-methyl-2,6,8-trioxa-14-azapentacyclo[11.7.1.0³,¹¹.0⁵,⁹.0¹⁷,²¹]henicosa-1(21),3,5(9),10,17,19-hexaene-16,20-diol

14-methyl-2,6,8-trioxa-14-azapentacyclo[11.7.1.0³,¹¹.0⁵,⁹.0¹⁷,²¹]henicosa-1(21),3,5(9),10,17,19-hexaene-16,20-diol

C18H17NO5 (327.1107)


   

(2s)-2-{[(2e)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

(2s)-2-{[(2e)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C18H17NO5 (327.1107)


   

(12s)-18-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14(19),15,17-hexaene-11,17-diol

(12s)-18-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14(19),15,17-hexaene-11,17-diol

C18H17NO5 (327.1107)


   

2-[(3-hydroxy-2h-1,4-benzoxazin-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(3-hydroxy-2h-1,4-benzoxazin-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C14H17NO8 (327.0954)


   

(1r,2s)-1,6-dihydroxy-2-(2-hydroxypropan-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one

(1r,2s)-1,6-dihydroxy-2-(2-hydroxypropan-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one

C18H17NO5 (327.1107)


   

(1r,2s)-1,2,9-trihydroxy-3,3-dimethyl-1h,2h,11h-pyrano[3,2-a]carbazole-5-carbaldehyde

(1r,2s)-1,2,9-trihydroxy-3,3-dimethyl-1h,2h,11h-pyrano[3,2-a]carbazole-5-carbaldehyde

C18H17NO5 (327.1107)


   

11-hydroxy-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,15,17-pentaen-14-one

11-hydroxy-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,15,17-pentaen-14-one

C18H17NO5 (327.1107)


   

2-{[3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-phenylpropanoic acid

2-{[3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-phenylpropanoic acid

C18H17NO5 (327.1107)


   

5-hydroxy-3,4-bis(1h-indol-3-yl)pyrrol-2-one

5-hydroxy-3,4-bis(1h-indol-3-yl)pyrrol-2-one

C20H13N3O2 (327.1008)


   

(13s,16r)-14-methyl-2,6,8-trioxa-14-azapentacyclo[11.7.1.0³,¹¹.0⁵,⁹.0¹⁷,²¹]henicosa-1(21),3,5(9),10,17,19-hexaene-16,20-diol

(13s,16r)-14-methyl-2,6,8-trioxa-14-azapentacyclo[11.7.1.0³,¹¹.0⁵,⁹.0¹⁷,²¹]henicosa-1(21),3,5(9),10,17,19-hexaene-16,20-diol

C18H17NO5 (327.1107)


   

1,6-dihydroxy-2-(2-hydroxypropan-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one

1,6-dihydroxy-2-(2-hydroxypropan-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one

C18H17NO5 (327.1107)


   

(2s,3r,4s,5s,6r)-2-[(3-hydroxy-2h-1,4-benzoxazin-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-[(3-hydroxy-2h-1,4-benzoxazin-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C14H17NO8 (327.0954)


   

5-(5,7-dimethoxy-3-oxo-1h-2-benzofuran-1-yl)-2-(prop-1-en-1-yl)-1h-pyridin-4-one

5-(5,7-dimethoxy-3-oxo-1h-2-benzofuran-1-yl)-2-(prop-1-en-1-yl)-1h-pyridin-4-one

C18H17NO5 (327.1107)


   

(2s,3r,4s,5s,6r)-2-{[(2r)-3-hydroxy-2h-1,4-benzoxazin-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(2r)-3-hydroxy-2h-1,4-benzoxazin-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C14H17NO8 (327.0954)


   

3-(4-hydroxy-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)-2-oxoethyl]prop-2-enimidic acid

3-(4-hydroxy-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)-2-oxoethyl]prop-2-enimidic acid

C18H17NO5 (327.1107)


   

(2s)-2-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-phenylpropanoic acid

(2s)-2-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-phenylpropanoic acid

C18H17NO5 (327.1107)


   

(1r,2r)-1,6-dihydroxy-2-(2-hydroxypropan-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one

(1r,2r)-1,6-dihydroxy-2-(2-hydroxypropan-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one

C18H17NO5 (327.1107)


   

8-methoxy-16-[(3-methylbut-2-en-1-yl)oxy]-4,12,14-trioxa-2-azatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1(16),2,5,7,9,11(15)-hexaene

8-methoxy-16-[(3-methylbut-2-en-1-yl)oxy]-4,12,14-trioxa-2-azatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1(16),2,5,7,9,11(15)-hexaene

C18H17NO5 (327.1107)


   

5-[(1r)-5,7-dimethoxy-3-oxo-1h-2-benzofuran-1-yl]-2-[(1e)-prop-1-en-1-yl]-1h-pyridin-4-one

5-[(1r)-5,7-dimethoxy-3-oxo-1h-2-benzofuran-1-yl]-2-[(1e)-prop-1-en-1-yl]-1h-pyridin-4-one

C18H17NO5 (327.1107)


   

(11s,15r)-14-hydroxy-3,13,18-triazahexacyclo[14.6.1.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁹,²³]tricosa-1(23),2(10),4,6,8,13,16,19,21-nonaen-12-one

(11s,15r)-14-hydroxy-3,13,18-triazahexacyclo[14.6.1.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁹,²³]tricosa-1(23),2(10),4,6,8,13,16,19,21-nonaen-12-one

C20H13N3O2 (327.1008)


   

(1s,12r,19r)-12-hydroxy-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,15,17-pentaen-11-one

(1s,12r,19r)-12-hydroxy-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,15,17-pentaen-11-one

C18H17NO5 (327.1107)


   

methyl (2e)-4-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methylbut-2-enoate

methyl (2e)-4-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methylbut-2-enoate

C18H17NO5 (327.1107)


   

1,2,9-trihydroxy-3,3-dimethyl-1h,2h,11h-pyrano[3,2-a]carbazole-5-carbaldehyde

1,2,9-trihydroxy-3,3-dimethyl-1h,2h,11h-pyrano[3,2-a]carbazole-5-carbaldehyde

C18H17NO5 (327.1107)


   

(2r)-4-hydroxy-2-[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2h-1,4-benzoxazin-3-one

(2r)-4-hydroxy-2-[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2h-1,4-benzoxazin-3-one

C14H17NO8 (327.0954)


   

14-hydroxy-3,13,18-triazahexacyclo[14.6.1.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁹,²³]tricosa-1(23),2(10),4,6,8,13,16,19,21-nonaen-12-one

14-hydroxy-3,13,18-triazahexacyclo[14.6.1.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁹,²³]tricosa-1(23),2(10),4,6,8,13,16,19,21-nonaen-12-one

C20H13N3O2 (327.1008)


   

6,7-dihydroxy-3-(2-hydroxy-4-methoxyphenyl)-5-(hydroxymethyl)-tetrahydro-3ah-pyrano[2,3-d][1,3]oxazol-2-one

6,7-dihydroxy-3-(2-hydroxy-4-methoxyphenyl)-5-(hydroxymethyl)-tetrahydro-3ah-pyrano[2,3-d][1,3]oxazol-2-one

C14H17NO8 (327.0954)